Locally Advanced or Metastatic Lung Adenocarcinomas with Egfr Mutantions. Treatment Experience and Advers Events
Alvydas Česas, Aušra Bankauskaitė, Jolanta Česienė, Jūratė Kasnauskienė Abstract Non-small-cell lung cancer (NSCLC) remains the leading causeof cancer-related death. Platinum-based doublet chemotherapyhas been a standard for patients with advanced stage disease.Improvements in overall survival and quality of life have beenmodest. Over the past decade, a large number of studies havebeen published that aimed to target…